Could raTCD Replace TTE for Shunt Screening After Stroke?

Recent advancements suggest that robot-assisted transcranial Doppler (raTCD) could potentially replace transthoracic echocardiography (TTE) for detecting right-to-left shunt (RLS) after cryptogenic stroke. A study by Rubin et al., published in Stroke, highlights the significant potential of raTCD. With cryptogenic strokes accounting for nearly 45% of non-lacunar ischemic strokes, identifying a patent foramen ovale (PFO) through accurate screening is crucial. Traditional TTE, although commonly used, shows poor sensitivity compared to the nonsurgical gold standard, transesophageal echocardiography (TEE). The study demonstrated that raTCD, operable without prior TCD skills, has a comparable sensitivity and specificity to TEE, making it a promising alternative.

Study Findings: raTCD vs. TTE Sensitivity and Specificity

In a multicenter clinical trial involving 129 participants across six U.S. sites, raTCD detected RLS in 64% of cases compared to TTE’s 20%. Particularly noteworthy was raTCD’s effectiveness in identifying large shunts, which TTE often missed. Despite concerns about false positives, the study provided compelling evidence with no serious adverse events related to the device. These findings indicate that raTCD could significantly improve RLS detection rates, leading to better secondary stroke prevention strategies. Given its ease of use and superior detection capability, should raTCD become the new standard for PFO screening in cryptogenic stroke patients? Read more to explore the full implications of this groundbreaking study.